IE00B4Q5ZN47
IE00B4Q5ZN47
Jazz Pharmaceuticals plc
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 4.267.586.000 | 4.068.950.000 | 4.9% |
| Cost of Revenue | 503.296.000 | 445.713.000 | 12.9% |
| Gross Profit | 3.764.290.000 | 3.623.237.000 | 3.9% |
| 3.246.668.000 | 2.896.607.000 | 12.1% | |
| Operating Income | 517.622.000 | 726.630.000 | 28.8% |
| Pretax Income | -627.859.000 | 470.351.000 | 233.5% |
| Net Income Common Stockholders | -356.148.000 | 560.120.000 | 163.6% |
| -- | -- | -- | |
| -- | -- | -- |